pubmed-article:19802667 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19802667 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:19802667 | lifeskim:mentions | umls-concept:C0278512 | lld:lifeskim |
pubmed-article:19802667 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:19802667 | pubmed:dateCreated | 2009-10-5 | lld:pubmed |
pubmed-article:19802667 | pubmed:abstractText | The prognosis for patients with metastatic osteosarcoma is still poor despite the development of effective adjuvant and neoadjuvant chemotherapy regimens. We have developed caffeine-potentiated chemotherapy for treatment of high-grade bone and soft tissue sarcomas based on the ability of caffeine to enhance the cytocidal effects of anticancer drugs. We report results of caffeine-potentiated chemotherapy for patients with osteosarcoma with pulmonary metastases. | lld:pubmed |
pubmed-article:19802667 | pubmed:language | eng | lld:pubmed |
pubmed-article:19802667 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19802667 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19802667 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19802667 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19802667 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19802667 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19802667 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19802667 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19802667 | pubmed:month | Sep | lld:pubmed |
pubmed-article:19802667 | pubmed:issn | 1436-2023 | lld:pubmed |
pubmed-article:19802667 | pubmed:author | pubmed-author:TomitaKatsuro... | lld:pubmed |
pubmed-article:19802667 | pubmed:author | pubmed-author:TsuchiyaHiroy... | lld:pubmed |
pubmed-article:19802667 | pubmed:author | pubmed-author:KimuraHiroaki... | lld:pubmed |
pubmed-article:19802667 | pubmed:author | pubmed-author:TakeuchiAkihi... | lld:pubmed |
pubmed-article:19802667 | pubmed:author | pubmed-author:HayashiKatsuh... | lld:pubmed |
pubmed-article:19802667 | pubmed:author | pubmed-author:ShiraiToshiha... | lld:pubmed |
pubmed-article:19802667 | pubmed:author | pubmed-author:NishidaHideji... | lld:pubmed |
pubmed-article:19802667 | pubmed:author | pubmed-author:OhnariIsseiI | lld:pubmed |
pubmed-article:19802667 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19802667 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:19802667 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19802667 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19802667 | pubmed:pagination | 556-65 | lld:pubmed |
pubmed-article:19802667 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:meshHeading | pubmed-meshheading:19802667... | lld:pubmed |
pubmed-article:19802667 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19802667 | pubmed:articleTitle | Caffeine-potentiated chemotherapy for metastatic osteosarcoma. | lld:pubmed |
pubmed-article:19802667 | pubmed:affiliation | Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan. | lld:pubmed |
pubmed-article:19802667 | pubmed:publicationType | Journal Article | lld:pubmed |